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Abstract
We have employed a novel approach for the identification of functionally important microRNA (miRNA)-target interactions,
integrating miRNA, transcriptome and proteome profiles and advanced in silico analysis using the FAME algorithm. Since
miRNAs play a crucial role in the inner ear, demonstrated by the discovery of mutations in a miRNA leading to human and
mouse deafness, we applied this approach to microdissected auditory and vestibular sensory epithelia. We detected the
expression of 157 miRNAs in the inner ear sensory epithelia, with 53 miRNAs differentially expressed between the cochlea
and vestibule. Functionally important miRNAs were determined by searching for enriched or depleted targets in the
transcript and protein datasets with an expression consistent with the dogma of miRNA regulation. Importantly, quite a few
of the targets were detected only in the protein datasets, attributable to regulation by translational suppression. We
identified and experimentally validated the regulation of PSIP1-P75, a transcriptional co-activator previously unknown in the
inner ear, by miR-135b, in vestibular hair cells. Our findings suggest that miR-135b serves as a cellular effector, involved in
regulating some of the differences between the cochlear and vestibular hair cells.
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Introduction
MicroRNAs (miRNAs) are small (17–24 nucleotide-long) non-
coding RNAs processed from the transcripts of endogenous genes
that function through the RNA interference (RNAi) pathway [1].
Specifically, by binding to sequences in the 39 untranslated region
(UTR) of genes, a miRNA can inhibit target mRNAs. Inhibition
occurs either by translational suppression and mRNA destabiliza-
tion of mRNAs with imperfect complementary sequences,
common in mammals, or by cleavage of mRNAs with a perfect
match to their sequence, common in plants [2,3]. In the former, it
is believed that conserved pairing to the 59 region of the miRNA
centers on nucleotides 2–7, named the "seed", is important for
miRNA target recognition [2]. To date, approximately 200 broad
evolutionarily conserved miRNA families and hundreds of
additional poorly conserved miRNAs have been identified in
mammals [4]. It has been estimated that approximately two thirds
of all human protein-coding genes are conserved targets of
miRNAs [5]; hence, miRNAs provide a widespread mechanism
for posttranscriptional control of gene expression. miRNAs have
been implicated in multiple biological processes, including
development and differentiation, proliferation, oncogenesis, in-
flammation, hematopoiesis, and angiogenesis [6–10]. Recently, a
mutation in miR-96 was found to underlie hereditary hearing loss
in humans [11] and mice [12]. To date, this is the only reported
example of a miRNA mutation causing a Mendelian disease.
The classical approach to understanding biological roles of
miRNAs has been to identify their targets and study their function
in the relevant system. However, methods for predicting miRNA
targets have proved to be a major barrier in the field, mainly due
to the incomplete understanding of miRNA target gene binding
interaction. While computational target prediction algorithms
provide large lists of proposed miRNA targets, a relatively limited
number have been validated. To improve the likelihood of
identifying biologically relevant targets, studies often utilize
microarray analysis to determine the expression profiles of
miRNAs and their predicted target mRNAs (e.g. [8,13,14]).
Although recent studies demonstrate that repression of proteins is
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18195frequently mirrored by decreased transcript levels of miRNA
targets [15–17], examples where translational repression is the
major component of silencing have been identified as well [17–
19]. Therefore, studying both the mRNA and protein levels
provides the most informative view of miRNA regulation and their
functional roles in particular tissues or organs.
The mammalian inner ear is composed of the auditory system
(cochlea) and the balance system (vestibule). The sensory organs of
these systems are specialized epithelia comprised of hair cells and
supporting cells. While the cochlea consists of a single sensory
organ the vestibule consists of five sensory patches, three at the end
of the semicircular canals that sense rotational movement, and the
saccule and utricle that sense linear acceleration. Sound,
movement and acceleration cause deflection of hair cell apical
projections, named stereocilia, located at the luminal surface of the
epithelium. This results in an influx of positively charged ions into
the cells, creating a graded receptor potential that causes release of
a neurotransmitter and stimulates an action potential in the
postsynaptic neurons to propagate the signal to the central nervous
system [20]. Thus the peripheral auditory and vestibular systems
have multiple similarities, with some striking differences in the
composition of accessory structures, support cells and hair cell fine
structure [21]. Therefore, comparative analysis of the miRNAs
expressed in these two systems is likely to identify tissue-specific
key regulators of post-transcriptional control of gene expression.
In this study, we identify functionally important miRNA-target
pairs in the mammalian inner ear through an in silico prediction
model that integrates miRNA, mRNA and protein expression.
Our approach addresses specific characteristics of miRNA
regulation including the number of miRNAs regulating each
target, the number of target sites within the target gene 39 UTR,
the 39 UTR length and the biological context of the regulation.
We examined the differential expression landscapes of miRNAs,
mRNAs, and proteins in the mouse postnatal day 2 (P2) inner ear
cochlear and vestibular sensory epithelia, with its underlying
mesenchyme. Thus, we present a comprehensive expression
profile of the sensory organs of the inner ear. We found significant
enrichment and depletion of targets for 13 and 20 miRNA
families, respectively, in the differentially expressed mRNA and
protein sets. In nine of the interactions, the miRNA was
differentially expressed between the two tissues. Notably, for five
of these interactions, the targets were identified only in the protein
expression sets. Six miRNA families appear to be functionally
important in the inner ear, as demonstrated by the enrichment or
depletion of their predicted targets and correlated change in tissue-
specific expression. For two miRNAs, miR-135b and miR-205, we
localized their cell specific expression in the inner ear using in situ
hybridization. Furthermore, we demonstrated the translational
regulation of PC4 and SFRS1 interacting protein 1 (PSIP1), a
transcriptional coactivator previously unknown to function in the
inner ear, by miR-135b. Our approach represents a generalizable
strategy that can be extended to functional studies of miRNAs in
organs or tissues of interest.
Results
Identification of miRNAs expressed in the cochlear and
vestibular sensory organs
To specifically evaluate miRNA expression profiles from mouse
cochlear and vestibular sensory epithelia, the mercury LNA
TM
miRNA array platform was utilized. This array platform contains
quadruplicate probes for 568 miRNAs; of these, 341 are known in
mouse and 447 are known in human, with an overlap of 220
miRNAs between the two species.
After filtering out signals of low intensity, 157 miRNAs were
detected in one or both tissues (see Methods). Of these, 138
miRNAs were found to be expressed in the cochlea, 146 miRNAs
in the vestibule, and 127 in both organ systems (Table S1).
Importantly, well established tissue-specific miRNAs, which are
not expected to be expressed in the inner ear, such as mir-1/206,
mir-155, mir-122 and mir-375, were not detected in either organ
by our microarray analysis. Moreover, well characterized inner ear
miRNAs, such as the three members of the miR-183/96/182
cluster were detected in both tissues.
We identified 52 miRNAs as being differentially expressed
between cochlear and vestibular sensory epithelia with a fold
change of at least 1.25 and P,0.05 (n=3, see Methods). Of these,
31 were up-regulated in the vestibule and 21 in the cochlea
(Figure 1A). Many of these differentially expressed miRNA genes
are clustered together in the mouse genome (Figure 1B). These
include the mir-183/96/182 cluster that had a higher expression
in the vestibule (fold change of 1.4–1.5) as well as two members of
each of the mir-17/92 and mir-106a/363 clusters, which had a
higher expression in the cochlea. Interestingly, we found that eight
of the miRNAs preferentially expressed in the vestibule were
located in the large miRNA cluster on chromosome 12qF1, which
contains 55 miRNAs mostly of unknown function [22]. Only one
miRNA from this cluster had a higher expression in the cochlea
(miR-377).
The differentially expressed miRNAs include four pairs of
mature miRNAs derived from the same pre-miRNA hairpin (miR-
467a and miR-467a*, miR-434-5p and miR-434-3p, miR-199a
and miR-199a*, miR-126-3p and miR-126-5p). As expected,
miRNAs derived from the same hairpin were expressed at a
similar level in the same tissue.
The miRNAs with the greatest differential expression were
miR-135b (expressed 2.5 times higher in the vestibule) and miR-
124a (expressed 4 times higher in the cochlea). Their expression
was confirmed (P,0.05) using quantitative real-time RT-PCR
(qRT-PCR). miR-135b was up-regulated 4-fold in the vestibule
and miR-124a was up-regulated 8-fold in the cochlea (Figure 1C).
Four additional miRNAs, miR-299, miR-182, miR-23a and miR-
125b, representing varying degrees of differential expression were
validated using qRT-PCR. In all cases the PCR analysis was
consistent with results of the microarray analysis (Figure 1C).
These results, together with the concordant expression changes
identified in miRNAs located in the same genomic cluster,
belonging to the same sequence similarity group, and originating
from the same hairpin, supports the validity of the above
mentioned miRNA array analysis.
mRNA and protein profiling in the cochlear and
vestibular sensory organs
As miRNAs target mRNA stability and translation, we utilized
Affymetrix GeneChipH MOE 430 2.0 arrays and mass spectrom-
etry to identify transcript expression and protein levels, respec-
tively in cochlear and vestibular sensory epithelia from P2 mice.
Although in some cases miRNAs were shown to repress expression
of their targets by 50% or more, recent studies, that identified
miRNA targets on a genomic scale, demonstrated that individual
miRNAs commonly repressed targets to only a modest degree in
the range of 20%–50% [15]. As one of the major goals of our
study is to correlate between miRNA and target transcript
expression, we therefore used a cutoff of at least 30% difference
in our expression analysis and a FDR of 10% using the Benjamini-
Hochberg correction for multiple testing. We identified 1,365
genes with greater expression in the vestibular system and 488 with
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PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e18195Figure 1. Differential miRNA expression profile in the cochlear and vestibular sensory epithelia. (A) Heat map representation of the 52
differentially expressed miRNAs between the P2 cochlear and vestibular sensory epithelia (fold change of at least 1.25 and P,0.05). The log2 of the
ratio between the expression in the vestibular epithelial and the cochlea is shown. Results were averaged for three independent experiments,
designated by three columns, each with two technical replicates. miRNAs shown in figure 1B are labeled by a grey box. (B) miRNA clusters
differentially expressed in the studied tissues. miRNAs up-regulated in vestibule are marked in red and those up-regulated in cochlea are marked in
green. Other miRNAs in the same clusters are not shown. miR-377 is the only member of the large miRNA cluster on chromosome 12qF1 significantly
up-regulated in the cochlea. (C) qRT-PCR analysis of selected miRNAs. miR-135b and miR-124a, the miRNAs with the highest differential expression in
the array, exhibited significant differential expression between the cochlear and vestibular sensory epithelia in the validation (4-fold and 8-fold,
respectively). n=3; (*) P,0.05, (**) P,0.005 versus the other tissue. miR-299, miR-182, miR-23a and miR-125b are representative of varying degrees of
differential expression in the array. All PCR results were consistent with the array results. n=3. Abbreviations: co-cochlea; ves-vestibule; oc-organ of
Corti; s-saccule; u-utricle; c-cristea.
doi:10.1371/journal.pone.0018195.g001
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least 1.3, Table S2).
In order to functionally characterize transcripts that are
differentially expressed between the two tissues, we searched for
enrichment of Gene Ontology (GO) ‘biological process’ annota-
tions (see Methods). Table S3 lists the GO biological process
annotations enriched at FDR,0.05 for each gene set. Both the
cochlear and vestibular gene sets were significantly enriched for
many developmental, morphogenesis and differentiation-related
GO terms.
In addition to analyzing transcript expression, we completed a
comprehensive protein profile of the cochlear and vestibular
sensory epithelia. To this end, we implemented a relative
quantitative proteomics approach using mass spectrometric
analysis of isobaric stable isotope labeled peptides (iTRAQ). We
identified a total of 456 proteins in one or both tissues. Applying a
threshold of at least 1.3 fold change, 63 proteins were found to be
more abundant in the vestibular sensory epithelia, while 48
proteins were found to be more abundant in the cochlear sensory
epithelia (Table S4).
To ascertain the relationship between the transcript expression
and protein abundance, we compared the differential expression
ratios observed in the two datasets. For the 424 genes for which
both transcript and protein levels were measured, the correlation
between the vestibule to cochlea ratios in the transcript and
protein datasets was moderate but significant (Spearman correla-
tion 0.2, P=2.45*10
25, Pearson correlation 0.32) (Figure S1A).
To detect the global structure of the data, the expression of the
genes measured at both the transcript and protein levels was
subjected to hierarchical clustering (Figure S1B). This analysis
shows clear division of the profiles into branches according to
tissue of origin, as protein and mRNA samples from the same
tissue were consistently clustered together.
The expression of fourteen genes was found to be enriched in
the vestibule by more than 30%, both on the transcript
(FDR,0.1) and the protein level, and four genes were found to
be significantly higher in the cochlea both on the transcript and
the protein level. In both cases, the overlap was highly statistically
significant (P=4.58?1026 and P=0.0012, respectively). Con-
versely, we identified two instances where transcripts were higher
in the cochlea, while the corresponding protein had a higher
abundance in the vestibule (P=0.83) (Figure S1C). We did not
identify any examples of higher mRNA expression in the vestibule
coupled with higher protein level in cochlea.
Identification of functionally relevant miRNA targets by
integration of mRNA and protein expression with in silico
target prediction
To delineate miRNA targets in the cochlear and vestibular
sensory epithelia, we performed a target analysis by combining in
silico analysis and experimental results. We applied the FAME
(Functional Assignment of MiRNA via Enrichment) algorithm
[23], a recently developed miRNA functional analysis tool, on our
transcript and protein datasets. FAME uses a permutation-based
statistical test to detect significant over- or under-representation of
miRNA targets in a designated set of genes, utilizing TargetScan
5.0 miRNA target predictions [5]. Unlike standard statistical tests,
it utilizes context scores for miRNA-target pairs, and accounts for
the number of miRNAs regulating each target and for the number
of target sites in the target gene 39 UTR [23]. Using the FAME
algorithm, we analyzed enrichment and depletion of miRNA
targets in the sets of genes down-regulated in one tissue compared
to the other at the mRNA level, the protein level or both (see
Figure 2C for a description). In addition, as some evidence shows
that miRNAs can regulate their targets solely at the protein level,
we independently tested a set of genes that were differentially
expressed only at the protein level but not at the mRNA level.
Overall, these eight sets of genes were tested for enrichment or
depletion of target sites for 199 miRNA families that both had
target predictions and were represented on our miRNA micro-
array (Table S5). Based on previous findings [24], conserved
predicted targets were used in enrichment tests, whereas both
conserved and nonconserved predicted targets were used when
testing for depletion.
We found significant enrichment (P,0.05) for targets of 13
miRNA families in six differentially expressed mRNA and/or
protein sets and depletion of targets of 20 miRNA families in six
differentially expressed sets (Figure 2A). Notably, many of the
significant enrichments were found only in the proteomics-based
sets and not in the mRNA-based sets. Nine of the 33 miRNA
families with significant enrichment or depletion in at least one set
were differentially expressed between the two tissues in our
miRNA microarray data. For these families we found five
significant enrichments and eight significant depletions of their
targets (Figure 2B). Out of these, nine were in the expected
direction. For example, the targets of the mir-135 family, a family
that was up-regulated in the vestibule, were enriched in a set of
proteins down-regulated in this tissue; and the targets of mir-205, a
miRNA that exhibited a higher expression in the cochlea, were
depleted in a set of proteins also up-regulated in the cochlea. We
noted that targets of mir-135 were marginally enriched in the set of
all proteins up-regulated in the cochlea (P=0.075), and a
statistically significant enrichment was found only when consider-
ing genes up-regulated in the cochlea only on the protein level (i.e.,
genes without significant mRNA changes between the two tissues,
P=0.047). Thus, for six miRNA families – mir-135, mir-205, mir-
142-3p, mir-15/16, mir-218 and mir-24 - we obtained evidence
for their functional relevance in the inner ear on two levels: (a) the
miRNAs were differentially expressed between the two tissues; and
(b) their predicted targets were differentially expressed in a manner
consistent with the currently accepted model of miRNA
regulation.
Spatial expression of selected miRNAs
For further study, we selected miR-135b and miR-205, for
which miRNA target enrichment or depletion, respectively, were
detected only at the protein expression level and therefore would
not have been identified by analyzing transcript data alone. The
spatial expression pattern of miR-135b and miR-205 in the inner
ear of P0 mice was determined using in situ hybridization (ISH;
Figure 3), and suggested differences in miRNA function across the
cochlea and vestibular organs. Consistent with the miRNA
microarray results, miR-135b exhibited specific expression in
vestibular organs hair cells. In addition, miR-135b was detected in
the neurons of the vestibular and spiral ganglia. As expected from
the miRNA microarray data, miR-205 expression was mainly
limited to the cochlea. Almost all cochlear cells, including those of
the modiolus, were found to express miR-205. Some of the cells in
the auditory apparatus did not show miR-205 expression,
including many of the cells facing the scala media. We found
miR-205 to be expressed in cells of the spiral ligament, part of the
Reissner’s membrane, basilar membrane and apical surface of the
spiral limbus.
PSIP1 protein expression is up-regulated in the cochlea
as compared to the vestibule
We chose to focus on miR-135b due to its intriguing cell specific
expression pattern and its high differential expression between the
MicroRNA Target Regulation in the Inner Ear
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135b regulates three targets in the vestibule, PSIP1-P75 (also
called LEDGF) and PC4, two interacting transcriptional coacti-
vators [25,26] and ARCN1, a subunit of the coat protein I (COPI)
complex required for intracellular trafficking [27]. Each of the
targets contains a single sequence complementary to the miR-
135b seed within their 39 UTR. The P52 isoform of PSIP1 does
not have a target site within its 39UTR and is therefore not a
potential target of miR-135b. Significantly, this is the first time
these proteins have been identified in the inner ear. qRT-PCR
analysis confirmed the presence of Psip1 transcript in the sensory
epithelia of both the cochlea and the vestibule, and quantification
revealed a similar expression level in the two tissues (Figure 4A;
n=3, P=0.34; Student’s t-test). Semi-quantitative western blot
showed on average 9-fold decrease (n=3, P,0.05; Student’s t-test)
in PSIP1-P75 protein expression in the vestibular as compared to
the cochlear sensory epithelia (Figure 4B). Together, these data
demonstrate that while Psip1 is transcribed equally in the cochlear
and vestibular sensory epithelia, the translation to the P75 isoform
of this protein is inhibited in the vestibular epithelia.
The presence of PSIP1-P75 isoform in the inner ear was further
confirmed using immunohistochemistry. Its expression was
distributed heterogeneously in the nucleoplasm of the hair
(Figure 4C) and supporting cells both in the cochlea and vestibule,
forming a speckled pattern. Such a finding is consistent with
previous reports of PSIP1-P75 localization to chromatin in both
interphase and mitotic chromosomes [28,29]. Although PSIP1-
P75 displayed expression in both the cochlea and vestibule, the
level of expression cannot be compared quantitatively by this
technique.
miR-135b down-regulates PSIP1-P75 protein expression
The functional interaction between miR-135b and PSIP1-P75
was further determined by in vitro analysis utilizing an RNAi
approach and a luciferase reporter assay. Cal51, breast carcinoma,
cells were found to express high levels of miR-135b, and relatively
low levels of PSIP1-P75. Cal51 cells were transfected with either a
plasmid expressing shRNA targeting miR-135b or an anti-miR
negative control. qRT-PCR analysis revealed a reduction in miR-
135b expression and similar Psip1 mRNA expression level in both
the cells transfected with the shRNA targeting miR-135b and
transfected with the anti-miR negative control (Figure 4D; n=3,
P=0.66; Student’s t-test). Semi-quantitative western blot analysis
Figure 2. miRNA target identification by integration of mRNA and protein expression with in silico target prediction. (A) Enrichment
and depletion of miRNA targets in co-expressed clusters of mRNAs, proteins, both or proteins only down-regulated in either the cochlea or vestibule.
Green squares indicate over-representation of miRNA targets in a cluster and purple squares indicate under-representation. Only miRNA-target
cluster pairs with P,0.05 are shown. miRNAs shown in figure 2B are labeled by a grey box. (B) Differentially expressed miRNAs with significant target
enrichments and depletions. (Left) Enrichment and depletion of miRNA targets in the co-expressed clusters for miRNAs that showed differential
expression based on the miRNA array. (Right) The relative expression of the miRNAs on the left represented by the log of the ratio between the
expressions in the cochlea as compared to the vestibule. (C) An outline of our miRNA target identification approach. Circles represent miRNAs and
cochlea/vestibule cartoons represent mRNA/proteins sets that are differentially expressed between the two tissues. Arrows connect miRNA with
mRNA/protein sets that are significantly enriched with its predicted targets based on TargetScan predictions. Only miRNAs that have enriched
predicted targets in the differentially expressed gene sets are presented. Cases where a miRNA is differentially expressed between the two tissues
(shown in B) are marked by a grey circle, while other cases are marked by a brown circle. Abbreviations: co-cochlea; ves-vestibule.
doi:10.1371/journal.pone.0018195.g002
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the cells expressing shRNA targeting miR-135b (Figure 4E; as
compared to transfection with an anti-miR negative control. n=3,
P,,0.005; Student’s t-test). Subsequently, we subcloned the
39UTR of Psip1-P75 downstream of a luciferase gene, creating a
Luc-Psip1-P75-39UTR vector. Transient co-expression of this
vector with a miR-135b expressing vector revealed that miR-
135b reduced luciferase expression levels by approximately 40%
(Figure 4E; as compared to a mutated Luc-Psip1-P75-39UTR
control. n=3, P,,0.005; Student’s t-test). These results indicate
that miR-135b down-regulates the expression of PSIP1-P75
protein but does not affect the mRNA levels.
Discussion
We have employed a novel and generalizable method to
efficiently identify functional miRNA-target interactions in a
neuroepithelial tissue. This approach can be extended to any tissue
or organ of interest. Specifically, we investigated the differences
between sensory epithelia of the cochlear and vestibular portions
of the inner ear, in an attempt to decipher critical elements driving
differential gene regulation in each system.
In this study we describe a miRNA profile of the inner ear
sensory epithelia. To date, two studies profiled the miRNAs in the
whole inner ear and whole cochlea and vestibule [30,31]. By
focusing on a more specific tissue, our work aims to provide depth
and understanding of the inner ear organs with a primary sensory
role. We report the presence of 157 miRNAs in at least one of the
sensory epithelia in the inner ear, with 52 differentially expressed
between the cochlea and vestibule. A close analysis of the miRNA
differential profile revealed that many of the miRNAs co-expressed
in the studied tissues are clustered in the mouse genome. This
observation is consistent with the notion that clustered miRNAs
are usually expressed together as polycistronic, co-regulated units
[32]. The vestibular up-regulated miRNAs include all the
members of the miR-183/96/182 cluster previously demonstrated
to be specifically expressed in the mammalian inner ear hair cells
and ganglia [11,12,31]. As the amount of RNA obtained from the
dissected tissues is greater in the cochlea, due to its larger size, the
differential expression of these miRNAs might be due to the
different percentage of hair cell specific RNA in the total RNA
from each of the two tissues.
Specific expression profiles of a miRNA in a given tissue may
point to the particular role of the miRNA in that tissue. It has been
suggested that miRNAs serve as cell effectors among cells of
related fates [33]. Furthermore, it is believed that miRNAs play an
important role in terminal differentiation and maturation of
different cell types within a particular cell lineage, as well as
regulating cellular processes in differentiated cells during morpho-
genesis and homeostasis (reviewed in [34]). The cochlear and
vestibular sensory epithelia share many similarities and differences.
Specifically, the sensory cells embedded in these tissues function
Figure 3. Distinct spatial expression patterns of miR-135b and miR-205 in the newborn mouse inner ear. (A) Schematic illustrations of a
P0 whole inner ear, cochlea and vestibule: utricle (ut), saccule (sa), spiral ganglia (sg), scala media (sm), scala vestibule (sv), scala tympani (st). In
purple, cochlear hair cells (chc) and vestibular hair cells (vhc). (B-D) Specific expression patterns were demonstrated for the miRNAs by ISH in whole
mount inner ears, followed by cryosectioning. For each miRNA images of the whole inner ear (top) and magnified cochlea (middle) and vestibule
(utricle or saccule, bottom) are shown separately. (B) A probe for miR-182 was used as a positive control and confirmed probe penetration and
staining throughout the inner ear. miR-182 is expressed in the inner ear hair cells and spiral ganglia at this age [31]. Expression patterns for miR-135b
(C) and miR-205 (D) were consistent with the miRNA array analysis. Scale bars: 100 mm.
doi:10.1371/journal.pone.0018195.g003
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similar but not identical morphology. Both cell types have
stereocilia projections arranged in bundles but the shape and
arrangement of the bundles is different in the two systems [35,36].
Importantly, cochlear hair cells are unable to regenerate in the
mammal, while early vestibular hair cells are able to do so to some
extent [37,38]. We speculate that the miRNAs differentially
expressed between the cochlea or vestibule may participate in
regulating these tissue identities and maintaining their distinct
function.
Figure 4. miR-135b regulates PSIP1-P75 expression by inhibition of translation. (A) qRT-PCR showing the relative Psip1 transcript
expression in the cochlear and vestibular sensory epithelia (n=3, P=0.34). (B) PSIP1-P75 protein differential expression as measured by western
blotting. (Top) A representative blot comparing PSIP1-P75 expression in the cochlear and vestibular sensory epithelia. HSC70 loading control is shown
for both samples. (Bottom) Relative PSIP-P75 expression as measured using the Image J software and following averaging of three independent
experiments; (*) P,0.05 versus the vestibule. (C) Immunolabeling of PSIP1-P75 in P2 cochlear inner hair cells (green). Phalloidin stains the stereocilia
(red) and DAPI the nucleus (blue). PSIP1-P75 is localized specifically to the nucleus. Scale bar: 5 mm. A schematic representation of an inner hair cell is
shown to the right. (D, E) An RNAi system was used to measure the ability of miR-135b to reduce PSIP1-P75 protein expression. shRNA targeting miR-
135b (X-miR-135b, oligoengine) or an anti-miR negative control were transfected to Cal51 cells that naturally express miR-135b. After selection, miR-
135b and Psip1 mRNA levels were measured using qRT-PCR and the protein level of the P75 isoform was measured using semi-quantitative western
blot analysis. (D) qRT-PCR showing the relative Psip1 transcript expression (n=3, P=0.66). (E)( Top) A representative blot showing the relative PSIP1-
P75 protein expression. HSC70 loading control is shown for both samples. (Bottom) Relative PSIP1-P75 protein expression as measured using the
image J software and following averaging of three independent experiments. (F) Dual luciferase reporter assay showing the effect of miR-135b on
Psip1-P75-39UTR and Psip1-P75-39UTR-M in MCF-7 cells. Relative luciferase expression following averaging of three independent experiments, each
conducted in triplicates. (**) P,,0.005.
doi:10.1371/journal.pone.0018195.g004
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and protein profiles. We characterized the repertoire of differen-
tially expressed transcripts and proteins in the vestibular system as
compared to the cochlea. Several of the genes identified in our
analyses were previously studied in the inner ear and a few (e.g.,
crystallin [39] and cochlin [40]) have been shown to cause
deafness. However, many of the genes found to be expressed in the
inner ear sensory epithelia, according to the transcript and protein
datasets, have not been identified in the inner ear thus far, and
their functional role is yet unknown. Notably absent from the
proteomic dataset are hair cell-specific proteins. This is likely due
to the limitation of the iTRAQ mass-spec method to identify low
abundance proteins. The tissues studied contain different cell
types, making it difficult to predict the function of genes and
proteins within specific cell types. In order to understand their
functional relevance, the proteins identified would have to be
studied in depth individually.
The correlation between the vestibule to cochlea ratios of the
mRNA and the protein levels was relatively low, though
significant. This could be due to the limited protein expression
data or a relatively high level of post-transcriptional regulation.
Similar correlations between mRNA and protein changes were
previously observed in analyses of embryonic mouse brain tissues
[41], in gastric cancer cells [42] and in the yeast Saccharomyces
cerevisiae [43].
Currently, miRNA target identification is based primarily on
computational target predication algorithms. The vast number of
targets predicted by these algorithms raises the problem of
choosing which of these are worthy for experimental validation.
For example, searching for the potential targets of the 52
differentially expressed miRNAs using the TargetScan algorithm
led to the identification of 11,031 putative conserved targets.
Therefore, to narrow down the targets list and to detect miRNA-
target pairs with a higher likelihood for successful validation, we
utilized a strategy that combines in silico analysis and experimental
techniques.
To analyze enrichment or depletion of miRNA targets we
applied the FAME algorithm on our datasets of differentially
expressed transcripts and proteins. Genes preferentially co-
expressed with a miRNA have evolved to avoid targeting by that
miRNA [24]. Thus, depletion of targets is expected for genes that
are expressed in the same tissue as the miRNA [24,44]. We
therefore focused on miRNAs and targets with a reciprocal
expression and miRNAs and anti-targets (messages selectively
avoiding targeting to a miRNA; see [45]) with a similar expression
pattern. In some cases, miRNAs and their potential targets were
observed to have a similar expression pattern, and not a reciprocal
one as expected. Such a phenomenon might be explained by the
counter regulation of different posttranscriptional control mech-
anisms or by miRNA induced translation up-regulation as
previously observed for the miRNAs miR-369-3 and let-7 in cell
cycle arrest [46]. We note that some of the miRNA targets
predicted by the analysis could only be detected using our
proteomics data, while others were only identified using the
transcriptomics data. Thus by looking at both levels of expression
we were able to identify the most thorough list of miRNA-target
pairs. It should be pointed out that our power is limited by the
detection constraints of the proteomics screen, and thus we expect
this list to be only partial.
The most notable miRNA for which we identified translation-
ally repressed targets was miR-135b, the miRNA with the highest
differential expression in our dataset. miR-135b is located within
the first intron of the LEM domain containing 1 (Lemd1) gene.
Interestingly, our Affymetrix microarray analysis showed a high
expression of Lemd1 in the vestibular sensory epithelia. Therefore,
it is likely that miR-135b is transcribed as part of Lemd1, leading to
a similar expression pattern. To better understand miR-135b
function in the inner ear, we studied its spatial expression. In situ
hybridization demonstrated specific expression of miR-135b in
vestibular hair cells. No such expression was observed in the
cochlea, consistent with our microarray and qRT-PCR results.
The distinct expression pattern of miR-135b most probably points
to a specific regulation mechanism that exists in the vestibular hair
cells but not in the cochlear hair cells. To date, the only miRNAs
identified demonstrating inner ear hair cell specificity are part of
the miR-183/96/182 family [31]. Unlike miR-135b, these
miRNAs are expressed both in the cochlear and vestibular hair
cells.
Of the three putative targets of miR-135b, we chose to further
validate the interaction with the P75 isoform of PSIP1. PSIP1 is a
transcriptional coactivator involved in neuroepithelial differentia-
tion and neurogenesis [47]. In particular, it plays a role in gene
regulation in the epithelial cells of the lens and is considered to be
involved in cell fate determination [48]. Such functions correspond
well to possible involvement in the differentiation and mainte-
nance of the sensory epithelia in the inner ear. It is therefore not
surprising that PSIP1 is expressed in the inner ear sensory
epithelia, as demonstrated in this study. The Psip1 gene is
alternatively spliced into two different isoforms; P75, the larger
isoform, and P52 [26,49]. Of the two, only P75 contains a
sequence within its 39 UTR with the potential of being targeted by
miR-135b. Using qRT-PCR and semi quantitative western blot
analysis, we were able to demonstrate inhibition of PSIP1-P75
protein expression in the vestibular sensory epithelia suggesting
intervention by a translational regulation mechanism. In vitro
analysis further proved an interaction between miR-135b and
PSIP1-P75. Interestingly, the efficiency by which miR-135b
silences PSIP1-P75, as identified by our in vitro analysis, is much
higher than previously expected for targets with only a single
binding site for a miRNA seed [2]. Due to the limitation in
efficient transfection of inner ear organotypic cultures, we could
not show the direct interaction in vivo. Taken together, our results
demonstrate the regulation of PSIP1-P75 by miR-135b in
vestibular hair cells. According to our results, miR-135a also has
a higher level of expression in the vestibular as compared to the
cochlear sensory epithelia. Due to the similarity between miR-
135b and miR-135a, we predict that miR-135a also regulates
PSIP1-P75 in the vestibular system.
The overall effect of miR-135b in the inner ear is summarized
in Figure 5. In this scheme, we propose a unique mechanism by
which miR-135b down-regulates PSIP1-P75 expression in the
vestibular hair cells, whereas it remains relatively high in the
cochlea. Thus the effect of PSIP1-P75 transcriptional regulation is
more pronounced in the cochlear hair cells, leading to down-
stream perturbation that possibly influences the cell’s identity,
differentiation and maintenance. PSIP1-P75 was previously shown
to be involved in cell survival [50], protection against stress [51],
differentiation [52], cell fate determination [48] and is believed to
regulate genes involved in development [53]. We hypothesize that
PSIP1-P75 and miR-135b might play a role in regulating these
processes in the cochlear hair cells, whereas in vestibular hair cells
they are modulated by other miRNA. By this means, miR-135b
might serve as a cellular effector, involved in regulating the
differences between the cochlear and vestibular hair cells and thus
contributes to their distinct cell identities and maintaining their
specific functions. It should be pointed out that these processes
involve more intricate mechanisms that have yet to be revealed,
including the interplay among different miRNAs and proteins.
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many previously unknown inner ear sensory epithelia miRNAs.
We reason that miRNAs differentially expressed between the
cochlear and vestibular sensory epithelia may participate in
regulating the cellular identities of these tissues and maintaining
their distinct morphology and function. Using our target analysis
approach, we were able to identify both miRNA targets affected at
the mRNA level and ones only affected at the protein level.
Significantly, the identification of a bona-fide miRNA-target pair,
miR-135b and PSIP1-P75, predicts a role for this pair in inner ear
cell survival, protection against stress, differentiation, cell fate
determination and development, and may explain differences in
regeneration of vestibular vs. cochlear hair cells.
Materials and Methods
Animal handling
All procedures involving animals met the guidelines described in
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals and have been approved by the Animal Care
and Use Committees of Tel Aviv University (M-07-061 and M-08-
026).
Dissection approach
For miRNA, mRNA and protein expression profiling, as well as
the qRT-PCR and western blot analysis, cochlea and vestibular
sensory epithelia were dissected from P2 wild type C3H mice and
collected separately. The vestibular epithelia consisted of the
saccule, utricle and the lateral and anterior cristae. Both the
cochlear and vestibular sensory epithelia were dissected with their
underlying mesenchyme and attached neurons. Altogether three
pools of each tissue type were collected consisting of cochlear or
vestibular sensory epithelia dissected from 10 to 12 inner ears.
Microarrays and bioinformatics analysis
For miRNA expression profiling, dissections were conducted as
described above. Small RNA-containing total RNA was extracted
from samples using the miRVana
TM miRNA isolation kit
(Ambion). RNA quality was assessed using a nano-range
bioanalyzer (Agilent Technologies). miRNA microarrays, pro-
duced using an oligonucleotide probe library (miRCURY LNA
array ready to spot) purchased from Exiqon, were a kind gift from
Dr. Noam Shomron. Five micrograms of sample RNA were
directly labeled with either Hy3 or Hy5 using the miRCURY
LNA array labeling kit (Exiqon). Hybridization and washing of the
microarray slides were performed as recommended by Exiqon. In
order to overcome the difficulty of variations in spotted arrays,
three biological repeats were performed, each with two technical
repeats (dye swaps). Scanning was performed using an Agilent
DNA microarray scanner. The SpotReader software (Niles
Scientific) was used to generate raw intensity data. The array
data was normalized such that the average intensity in each
sample was the same. For each experiment color-swap technical
replicates were averaged and a single sample t-test analysis was
performed to extract differentially expressed genes. A miRNA was
considered detected if the spot intensity was at least two standard
deviations above background in at least two of the samples.
For mRNA profiling, dissections were as detailed above. Total
RNA was extracted using a standard Trizol protocol. RNA was
DNAseI treated (Qiagen), resuspended and quality assessed using
a nano-range bioanalyzer (Agilent Technologies). RNA was then
amplified using the Affymetrix two-cycle kit and hybridized to the
Affymetrix GeneChipH MOE 430 2.0 arrays as previously
described [41,54,55]. Three biological experiments were conduct-
ed, each with three replicates. Expression levels were computed
using the robust multiarray average (RMA) method (implemented
in the BioConductor package). To remove systematic biases
among the chips, they were normalized using the quantile
normalization scheme. To filter out probe sets whose correspond-
ing genes are not expressed in the analyzed samples, Presence flags
were computed according to Affymetrix MAS5 method. Probe sets
that got no ’Present’ calls were filtered out, leaving 29,636 probe
sets for subsequent analysis. Multiple testing was accounted for by
correcting the p-values using the Benjamini-Hochberg method to
control for the false discovery rate (FDR). Hierarchical clustering
with average linkage was performed using Expander [56]. GO
analysis on differentially expressed genes was performed using a
hypergeometric test, and corrected for multiple testing using the
Benjamini-Hochberg FDR method.
The gene expression dataset reported in this publication is
MIAME compliant and was deposited in the NCBI’s Gene
Expression Omnibus (GEO) database, NCBI [57] (GEO series
accession number GSE23081).
qRT-PCR
For qRT-PCR analysis of miRNAs expression in the inner ear,
dissections were conducted as detailed in the dissection approach.
For miR-135b regulation analysis in shRNA transfected Cal51
cells, transfected cells were lysed and frozen at -80uC. Small RNA-
containing total RNA was extracted from samples using either the
miRVana
TM miRNA isolation kit (Ambion) or the miRNeasy
Figure 5. Schematic representation of a possible role of miR-
135b in the inner ear. miR-135b (blue) is expressed in the vestibular
hair cells, whereas no expression is detected in the cochlear hair cells.
miR-135b down-regulates PSIP1-P75 (red) expression in the vestibular
hair cells while its expression remains relatively high in the cochlear hair
cells. Due to this differential expression, PSIP1-P75 regulates (red
arrows) different process in the cochlear hair cells and only to a lesser
extent in the vestibular hair cells. These processes include development,
differentiation, cell fate determination, cell survival and protection
against stress.
doi:10.1371/journal.pone.0018195.g005
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control) were reverse transcribed using the Taqman Reverse
Transcription kit (Applied Biosystems) and their expression was
measured using the Taqman microRNA qRT-PCR kits and the
ABI Prism 7900 PCR machine (Applied Biosystems). Reactions
were performed as three independent experiments, each with
three replicates. The miRNAs expression was normalized to the
expression of U6B.
For gene expression analysis, total RNA was extracted from the
separately collected epithelia using either the RNeasy Plus Mini
Kit (Qiagen) or the miRNeasy Mini Kit (total RNA protocol,
Qiagen). Total RNA was converted to single stranded cDNA using
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). qRT-PCR was performed using Taqman Gene
Expression Assay for Psip1 and either Tbp or RPLP0 and the 2X
Universal PCR Master Mix (Applied Biosystems). Three experi-
ments were performed, each in triplicates.
Quantitative protein profiling and mass spectrometry
Mass spectrometry was performed at the Smoler Proteomics
Center, Technion, Haifa, Israel. For quantitative protein profiling,
cochlear and vestibular sensory epithelia were dissected and
collected as described in dissection approach. Each pool consisted
of either cochlear or vestibular sensory epithelia collected from 50
to 60 inner ears. Proteins were extracted using a standard Trizol
protocol. Protein pellets (50 mg each) were resuspended separately
in 8 M urea in 100 mM ammonium bicarbonate and were
reduced (10 mM DTT) and modified with 40 mM iodoacetamide.
The samples were diluted to 2 M urea with water and the proteins
were trypsinized with 2 mg bovine trypsin at 37uC overnight (12 to
16 h). The resulted peptides were cleaned on disposable Silica-
C18 tip (Harvard) and resuspended in 100 mM Hepes (pH 7.3).
The iTRAQ
TM Reagent (Applied Biosystems) was brought to
room temp and then mixed with ethanol (30:70). After vortexing
and spinning, each one of the reagents was transferred to one
sample tube. The tubes were incubated at room temperature for
1 h. The two iTRAQ
TM reagent-labeled samples were combined,
cleaned on C18 and resuspended in 0.1% formic acid. 60 mg of the
combined labeled peptides were separated in an on-line two
dimensional chromatography experiment (MuDPiT). First the
peptides were loaded on 15 mm of BioX-SCX column (LC
Packing) and eluted with 8 salt steps of 0, 40, 100, 150, 200, 300,
500 mM and 1000 mM ammonium acetate in 5% ACN and
0.1% acetic acid, pH 3. The eluted peptides were further resolved
by capillary reverse-phase chromatography (75 m ID, 30 cm fused
silica capillaries, J&W self-packed with 3 ml Reprosil-Aqua C18).
The peptides were eluted using a 125 min gradient (5% to 40%
acetonitrile containing 0.1% formic acid) followed by a wash step
of 95% acetonitrile for 15 min. The flow rate was about 0.2 ml/
min and the peptides were analyzed using QTOF-Premier mass
spectrometer (Waters). Mass spectrometry was performed in a
positive mode using repetitively full MS scan followed by collision
induces dissociation (CID) of the 3 most dominant ion selected
from the first MS scan.
The mass spectrometry data was clustered, analyzed and
compared using the Pep-Miner [58] and Sequest software against
the mouse part of the nonredundant (nr) database (NCBI).
Quantitative analysis was done using an on-house tool comparing
the intensity of 114 and 115 ions in each MSMS spectrum. Only
proteins with three or more peptides were considered valid for the
ensuing analysis. For each peptide, the ratio between the iTRAQ
label peak value and the sum of intensities was calculated. The
ratio was normalized in relation to one and divided by the median
of the ratios. The raw proteomic data is attached as Table S6.
Western blot analysis
For comparison of PSIP1-P75 protein expression in the inner
ear sensory epithelia dissection was conducted as described above.
For miR-135b regulation analysis in shRNA transfected Cal51
cells, transfected cells were spun-down and frozen at -80uC. In
both cases, proteins were extracted using NP40 supplemented with
X100 protease and phosphotase inhibitors (Calbiochem and
Sigma respectively) and abundance was measured using a
Bradford assay (Sigma). Equal quantities of lysates were separated
by 8% SDS polyacrylamide gels, and electrophoretically trans-
ferred to polyvinylidene difluoride membranes (Millipore). Pro-
teins were analyzed by western blotting using rabbit anti-PSIP1-
P75 antibody (Cell Signaling Technology) and mouse anti-HSC70
antibody (Santa Cruz Biotechnology Inc.). HSC70 loading control
was used to normalize the abundance of specific proteins. Specific
proteins relative quantities were calculated using the Image J
software (NIH) with subsequent averaging of three separate
experiments.
In situ hybridization
At least three independent ISH experiments were performed
with each probe, and at least 4 inner ears were included in each
experiment. Inner ears of C57BL/6J new born mice were fixed in
4% paraformaldehyde (PFA). Whole mount in situ hybridization
analysis was performed according to the Exiqon protocol with a
few modifications [30]. Briefly, the tissues were incubated in
hybridization solution with miRCURY LNA
TM microRNA
detection probes (Exiqon), at 20–22uC below the melting
temperature of the probe. The LNA
TM digoxygenin (DIG) labeled
probes were detected by anti-DIG-AP (alkaline phosphatase
conjugated) antibody (Roche). NTB/BCIP (Sigma) was added to
develop the color reaction. The tissues were then cryosectioned to
10–18 mm sections using the LEICA CM3050S cryostat. The
sections were mounted and imaged using the Ziess Axiovert200 M
microscope.
miRNA Target prediction and enrichment analysis
miRNA target predictions were obtained from TargetScanMouse
5.0 (http://www.targetscan.org/mmu_50/). All the conserved tar-
gets for conserved miRNA families were used for over-representation
analysis, and both conserved and nonconserved targets for conserved
miRNA families were used for under-representation analysis. FAME
algorithm is described in detail in [23]. Briefly, TargetScan
predictions are used to construct a weighted bipartite graph in which
miRNAs are connected to their predicted targets. The edge weights
are based on the context scores assigned by TargetScan to each
miRNA target site. For each miRNA and each gene set, the total
weight of the edges between the miRNA and the genes in the set is
compared to the weight expected based on random perturbations of
the bipartite graph, which preserve the number of miRNAs targeting
each gene and the number of targets for each miRNA. This
comparison is used to derive an empirical p-value for the enrichment
of miRNA targets in the gene set.
Cell culture and transfection
Cells from the Cal51 [59] and MCF-7 (HTB-22
TM, ATCC),
breast carcinoma cell lines, were grown in DMEM supplemented
with 10% FCS (Beit Haemek Biological Industries) and antibiotics
(Invitrogene). For miR-135b inhibitor treatment, Cal51 cells were
transfected using JetPEI reagent (Polyplus transfection
TM) with a
pSUPER-GFP plasmid encoding either shRNAs against mouse
miR-135b or negative control shRNA (Oligoengine). Cells were
cultured for 48 h before selection with G418 Sulfate (Calbiochem).
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transfected cells died, approximately a week after selection
initiation. Total RNAs and proteins were extracted from
transfected and selected Cal51 cells as described above. Three
separate experiments were conducted.
Luciferase reporter assay
Luc-Psip-P75-39UTR was produced by subcloning the 39UTR
of Psip1-P75 into the pGL3 vector (Promega) downstream of the
luciferase gene by PCR with TCT AGAG GGA TTT CAG TGG
CAT TAG AA (forward) and TCT AGA AAC TTT AAT TAA
AAC AAT TTA CAC (reverse) primers. A control construct, Luc-
Psip1-P75-M, was created by removing the sequence, comple-
mentary to the miR-135b seed, using a AGT GTC AAT GTG
TAA ATT GTT TTA A phosphor-primer and a AAC TAG AAT
AAT TTT TGT CCA AGT T primer and the QuikChange II
Site-Directed Mutagenesis Kit (Agilent).
The luciferase reporter assay was performed as previously described
[60].Briefly,MCF-7 cells were grown in 24-well plates and transfected
using JetPEI reagent (Polyplus transfection
TM) with either 5 ng of Luc-
Psip1-P75-39UTR or a mutated control, 5 ng Renilla and 0.5 mgo f
miR-135b (miRNA expression vector obtained as a gift from Reuven
Agami, [61]). Luciferase activity was measured 72 h after transfection
using the Dual-LuciferaseH Reporter Assay System (Promega). Three
experiments were conducted, each in triplicates.
Immunohistochemistry
Whole mount immunohistochemistry was conducted as previously
described [62]. Briefly, inner ears from C3H P2 mice were fixed
overnight in 4% PFA (Electron Microscopy Sciences) in Dulbecco’s
phosphate-buffered saline (D-PBS) and washed in D-PBS after which
further fine dissection isolation of the cochlea and vestibular sensory
organs was conducted. Following permeabilization and blocking, the
tissues were incubated overnight at 4uC with rabbit anti-PSIP1-P75
specific antibody (Cell Signaling) diluted in D-PBS (1:50). Immuno-
labeling was visualized with an Alexa 488-conugated donkey anti-
rabbit antibody (diluted 1:500; Invitrogen), together with rhodamine
phalloidin (diluted 1:250; Invitrogen), an actin fluorescent dye. After
washes, samples were mounted on glass slides using ProLong gold
antifade reagent (Invitrogen). Confocal laser microscopy was carried
out with a Leica TCS SP5 laser confocal microscope.
Supporting Information
Figure S1 Relationship between differential cochlear and
vestibular transcript and protein datasets. (A) Scatter plot
representation of the protein cochlea to vestibule expression ratios
obtained by the iTRAQ labeling and MuDPiT analysis and
mRNA cochlea to vestibule expression ratios obtained from the
Affymetrix microarray. Both expression ratios are plotted in a
logarithmic scale. (B) Cluster dendrogram of the differentially
expressed mRNA and protein datasets. (C) Intersection of the
Affymetrix microarray (pink) and proteomic results (blue). Left
diagram: Genes significantly up-regulated in the cochlea both on
the mRNA and the protein levels. Middle diagram: Genes
significantly up-regulated in the vestibule both on the mRNA
and the protein levels. Right diagram: Genes up-regulated in the
cochlea on the mRNA level and in the vestibule on the protein
level. Fold difference of at least 30% and FDR,0.1; (**) P,0.005
versus the other tissue.
(TIF)
Table S1 miRNA detected in cochlear and vestibular sensory
epithelia.
(XLS)
Table S2 mRNA expression profile in cochlear and vestibular
sensory epithelia.
(XLS)
Table S3 GO ’biological process’ annotations enriched in the
mRNA gene sets.
(XLS)
Table S4 Protein expression profile in cochlear and vestibular
sensory epithelia.
(XLS)
Table S5 Enriched and depleted targets in the differentially
expressed mRNA and protein datasets.
(XLS)
Table S6 Complete protein data.
(XLS)
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